{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:20:32Z","timestamp":1789179632038,"version":"build-2803163510"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00278268"],"award-info":[{"award-number":["RS-2023-00278268"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001675","name":"International Brain Research Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001675","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019305","name":"Manipal Academy of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019305","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.arr.2024.102211","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T20:58:21Z","timestamp":1706821101000},"page":"102211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways"],"prefix":"10.1016","volume":"96","author":[{"given":"Jitendra Kumar","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchal","family":"Trisal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shampa","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Soo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhumita","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mosleh Mohammad","family":"Abomughaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali M.","family":"Abomughayedh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmajeed G.","family":"Almutary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danish","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Bhaskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhu Chandra","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh Kumar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj Kumar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9486-4069","authenticated-orcid":false,"given":"Abhishek Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2024.102211_bib1","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.neuropharm.2012.07.026","article-title":"MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus","volume":"63","author":"Anneken","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2024.102211_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11481-012-9420-x","article-title":"MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase","volume":"8","author":"Anneken","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.arr.2024.102211_bib3","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer\u2019s disease","volume":"377","author":"Ballard","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2024.102211_bib4","first-page":"846","article-title":"3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions","volume":"297","author":"Bankson","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.arr.2024.102211_bib5","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","article-title":"Brain-derived neurotrophic factor and its clinical implications","author":"Bathina","year":"2015","journal-title":"Arch. Med Sci. 11"},{"key":"10.1016\/j.arr.2024.102211_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuropharm.2018.02.018","article-title":"Psychedelics: where we are now, why we got here, what we must do","volume":"142","author":"Belouin","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2024.102211_bib7","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1021\/jm5003952","article-title":"Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer\u2019s disease","volume":"57","author":"Benham\u00fa","year":"2014","journal-title":"J. Med Chem."},{"key":"10.1016\/j.arr.2024.102211_bib8","series-title":"Emerging Anti-Aging Strategies","first-page":"41","article-title":"Autophagy as a promising therapeutic target in age-associated neurodegenerative disorders","author":"Bhaduri","year":"2023"},{"key":"10.1016\/j.arr.2024.102211_bib9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/joim.12816","article-title":"Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future","volume":"284","author":"Blennow","year":"2018","journal-title":"J. Intern Med"},{"key":"10.1016\/j.arr.2024.102211_bib10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2024.102211_bib11","first-page":"7","article-title":"Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone","volume":"265","author":"Blier","year":"1993","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.arr.2024.102211_bib12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/0269881114531666","article-title":"Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling","volume":"28","author":"Buchborn","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.arr.2024.102211_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41386-022-01389-z","article-title":"Towards an understanding of psychedelic-induced neuroplasticity","volume":"48","author":"Calder","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.arr.2024.102211_bib14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/jnc.14345","article-title":"The GABAergic system as a therapeutic target for Alzheimer\u2019s disease","volume":"146","author":"Calvo-Flores Guzm\u00e1n","year":"2018","journal-title":"J. Neurochem"},{"key":"10.1016\/j.arr.2024.102211_bib15","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/acschemneuro.8b00692","article-title":"Chronic, intermittent microdoses of the psychedelic N,N-Dimethyltryptamine (DMT) produce positive effects on mood and anxiety in rodents","volume":"10","author":"Cameron","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainresbull.2016.04.016","article-title":"Neuropharmacology of N,N-dimethyltryptamine","volume":"126","author":"Carbonaro","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.arr.2024.102211_bib17","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/npp.2017.84","article-title":"The therapeutic potential of psychedelic drugs: past, present, and future","volume":"42","author":"Carhart-Harris","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.arr.2024.102211_bib18","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1073\/pnas.1119598109","article-title":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin","volume":"109","author":"Carhart-Harris","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2024.102211_bib19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.npp.1300893","article-title":"Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats","volume":"31","author":"Carli","year":"2006","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.arr.2024.102211_bib20","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nrn3258","article-title":"Structural plasticity upon learning: regulation and functions","volume":"13","author":"Caroni","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3389\/fncel.2014.00401","article-title":"The role of AMPA receptors in postsynaptic mechanisms of synaptic plasticity","volume":"8","author":"Chater","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib22","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1021\/acschemneuro.1c00181","article-title":"Optimized TrkB agonist ameliorates alzheimer\u2019s disease pathologies and improves cognitive functions via inhibiting delta-secretase","volume":"12","author":"Chen","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib23","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1021\/acschemneuro.5b00135","article-title":"Serotonin: a new hope in alzheimer\u2019s disease?","volume":"6","author":"Claeysen","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/jox12010004","article-title":"Psilocybin for treating psychiatric disorders: a psychonaut legend or a promising therapeutic perspective?","volume":"12","author":"Coppola","year":"2022","journal-title":"J. Xenobiot."},{"key":"10.1016\/j.arr.2024.102211_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0079-6123(07)00020-9","article-title":"What are the differences between long-term, short-term, and working memory?","volume":"169","author":"Cowan","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.arr.2024.102211_bib26","article-title":"A simple role for BDNF in learning and memory?","volume":"1","author":"Cunha","year":"2010","journal-title":"Front. Mol. Neurosci. 3"},{"key":"10.1016\/j.arr.2024.102211_bib27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.phrs.2016.08.022","article-title":"The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors","volume":"113","author":"De Gregorio","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.arr.2024.102211_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.724606","article-title":"Psychedelics and neuroplasticity: a systematic review unraveling the biological underpinnings of psychedelics","volume":"12","author":"de Vos","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.arr.2024.102211_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.10069","article-title":"Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment","volume":"51","author":"DeKosky","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2024.102211_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-021-01706-y","article-title":"Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder","volume":"11","author":"Doss","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.arr.2024.102211_bib31","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3390\/cancers11101422","article-title":"The emerging roles of mTORC1 in macromanaging autophagy","volume":"11","author":"Dossou","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arr.2024.102211_bib32","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/cpt.3050","article-title":"Psychedelics and psychotherapy: is the whole greater than the sum of its parts?","volume":"114","author":"Dworkin","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.arr.2024.102211_bib33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/09540261.2018.1481827","article-title":"Psychedelics as anti-inflammatory agents","volume":"30","author":"Flanagan","year":"2018","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.arr.2024.102211_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2019.00004","article-title":"TrkB-ICD fragment, originating from BDNF receptor cleavage, is translocated to cell nucleus and phosphorylates nuclear and axonal proteins","volume":"12","author":"Fonseca-Gomes","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib35","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1073\/pnas.1918477117","article-title":"Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings","volume":"117","author":"Forstmann","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2024.102211_bib36","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-022-00279-0","article-title":"Brain-derived neurotrophic factor in Alzheimer\u2019s disease and its pharmaceutical potential","volume":"11","author":"Gao","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2024.102211_bib37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fnmol.2011.00022","article-title":"Revisiting the role of acetylcholinesterase in alzheimer\u2019s disease: cross-talk with p-tau and \u03b2-amyloid","volume":"4","author":"Garc\u00eda-Ayll\u00f3n","year":"2011","journal-title":"Front Mol. Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1037\/pha0000084","article-title":"Clinical applications of hallucinogens: a review","volume":"24","author":"Garcia-Romeu","year":"2016","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.arr.2024.102211_bib39","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","article-title":"Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases","volume":"202","author":"Gasser","year":"2014","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.arr.2024.102211_bib40","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s11030-022-10489-3","article-title":"Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system","volume":"27","author":"Gautam","year":"2023","journal-title":"Mol. Divers"},{"key":"10.1016\/j.arr.2024.102211_bib41","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2165\/11590190-000000000-00000","article-title":"Role of serotonin in Alzheimer\u2019s disease: a new therapeutic target?","volume":"25","author":"Geldenhuys","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.arr.2024.102211_bib42","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.4103\/0972-2327.74247","article-title":"Endocrine, metabolic, nutritional, and toxic disorders leading to dementia","volume":"13","author":"Ghosh","year":"2010","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.arr.2024.102211_bib43","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/iub.1532","article-title":"Epigenomic maintenance through dietary intervention can facilitate DNA repair process to slow down the progress of premature aging","volume":"68","author":"Ghosh","year":"2016","journal-title":"IUBMB Life"},{"key":"10.1016\/j.arr.2024.102211_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1351855","article-title":"Editorial: world digestive health day: investigating the link between neurodegenerative disease and gut microbiota","volume":"15","author":"Ghosh","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib45","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.1132814","article-title":"A century of Alzheimer\u2019s disease","volume":"314","author":"Goedert","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.arr.2024.102211_bib46","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.arr.2024.102211_bib47","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","article-title":"Microtubule-associated protein tau. A component of Alzheimer paired helical filaments","volume":"261","author":"Grundke-Iqbal","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102211_bib48","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0014-2999(94)90669-6","article-title":"Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists","volume":"264","author":"Gudelsky","year":"1994","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.arr.2024.102211_bib49","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-018-0444-2","article-title":"CHAT gene polymorphism rs3810950 is associated with the risk of Alzheimer\u2019s disease in the Czech population","volume":"25","author":"H\u00e1lov\u00e1","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.arr.2024.102211_bib50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/TGR.0b013e31821e588e","article-title":"Plasticity in early alzheimer\u2019s disease: an opportunity for intervention","volume":"27","author":"Hill","year":"2011","journal-title":"Top. Geriatr. Rehabil."},{"key":"10.1016\/j.arr.2024.102211_bib51","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv040","article-title":"Ketamine-induced modulation of the thalamo-cortical network in healthy volunteers as a model for schizophrenia","volume":"18","author":"H\u00f6flich","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.arr.2024.102211_bib52","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1091\/mbc.e08-12-1248","article-title":"Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy","volume":"20","author":"Hosokawa","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.arr.2024.102211_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-023-04115-6","article-title":"Outpatient opioid prescribing by Alzheimer\u2019s diagnosis among older adults with pain in United States","volume":"23","author":"Huang","year":"2023","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.arr.2024.102211_bib54","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/acsptsci.0c00099","article-title":"Low doses of LSD acutely increase BDNF blood plasma levels in healthy volunteers","volume":"4","author":"Hutten","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.arr.2024.102211_bib55","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1124\/pharmrev.120.000056","article-title":"Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms","volume":"73","author":"Inserra","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.arr.2024.102211_bib56","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1038\/s41380-023-02274-x","article-title":"Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics","volume":"28","author":"Jaster","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2024.102211_bib57","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1093\/cercor\/bhu105","article-title":"Dysregulation of TrkB receptors and BDNF function by amyloid-\u03b2 peptide is mediated by calpain","volume":"25","author":"Jer\u00f3nimo-Santos","year":"2015","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.arr.2024.102211_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105345","article-title":"Impaired plasticity of intrinsic excitability in the dentate gyrus alters spike transfer in a mouse model of Alzheimer\u2019s disease","volume":"154","author":"Jiang","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2024.102211_bib59","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1073\/pnas.1017033108","article-title":"Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration","volume":"108","author":"Jin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2024.102211_bib60","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archneurol.2008.534","article-title":"Rapidly progressive neurodegenerative dementias","volume":"66","author":"Josephs","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2024.102211_bib61","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","article-title":"APP processing and synaptic function","volume":"37","author":"Kamenetz","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102211_bib62","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1177\/1545968320962498","article-title":"Mental imagery as a rehabilitative therapy for neuropathic pain in people with spinal cord injury: a randomized controlled trial","volume":"34","author":"Kaur","year":"2020","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.arr.2024.102211_bib63","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.arr.2024.102211_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.00151","article-title":"Tau-mediated dysregulation of neuroplasticity and glial plasticity","volume":"13","author":"Koller","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib65","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/jnc.15509","article-title":"From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders","volume":"162","author":"Kozlowska","year":"2022","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102211_bib66","first-page":"e29167","article-title":"The use of psychedelics in the treatment of medical conditions: an analysis of currently registered psychedelics studies in the american drug trial registry","volume":"14","author":"Kurtz","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.arr.2024.102211_bib67","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41593-022-01177-4","article-title":"The neural basis of psychedelic action","volume":"25","author":"Kwan","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib68","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.tips.2017.08.003","article-title":"Psychedelic drugs in biomedicine","volume":"38","author":"Kyzar","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.arr.2024.102211_bib69","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3233\/JAD-210110","article-title":"Latent profile analysis of cognition in a non-demented diverse cohort: a focus on modifiable cardiovascular and lifestyle factors","volume":"82","author":"Lamar","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2024.102211_bib70","series-title":"The Dynamic Synapse: Molecular Methods in Ionotropic Receptor Biology, Frontiers in Neuroscience","article-title":"AMPA receptor phosphorylation in synaptic plasticity: insights from knockin mice","author":"Lee","year":"2006"},{"key":"10.1016\/j.arr.2024.102211_bib71","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.semcdb.2011.06.007","article-title":"AMPA receptor regulation during synaptic plasticity in hippocampus and neocortex","volume":"22","author":"Lee","year":"2011","journal-title":"Semin Cell Dev. Biol."},{"key":"10.1016\/j.arr.2024.102211_bib72","doi-asserted-by":"crossref","DOI":"10.1007\/s12152-023-09522-5","article-title":"Mild cognitive impairment in relation to alzheimer\u2019s disease: an investigation of principles, classifications, ethics, and problems","volume":"16","author":"Lee","year":"2023","journal-title":"Neuroethics"},{"key":"10.1016\/j.arr.2024.102211_bib73","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/gps.4086","article-title":"Mindfulness-based stress reduction for older adults with worry symptoms and co-occurring cognitive dysfunction","volume":"29","author":"Lenze","year":"2014","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.arr.2024.102211_bib74","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3928\/19404921-20220131-01","article-title":"Willingness to participate in clinical research among individuals with cognitive impairment","volume":"15","author":"Li","year":"2022","journal-title":"Res. Gerontol. Nurs."},{"issue":"5994","key":"10.1016\/j.arr.2024.102211_bib75","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.arr.2024.102211_bib76","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnagi.2016.00031","article-title":"Implications of GABAergic neurotransmission in alzheimer\u2019s disease","volume":"8","author":"Li","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib77","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0006-8993(97)00255-2","article-title":"Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex","volume":"759","author":"Lindefors","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.arr.2024.102211_bib78","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/7854_2017_478","article-title":"Hallucinogens and serotonin 5-HT2A receptor-mediated signaling pathways","volume":"36","author":"L\u00f3pez-Gim\u00e9nez","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.748359","article-title":"Serotonergic psychedelics in neural plasticity","volume":"14","author":"Lukasiewicz","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib80","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.arr.2024.102211_bib81","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2024.102211_bib82","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/ph15050640","article-title":"New Paradigms of Old Psychedelics in Schizophrenia","volume":"15","author":"Mahmood","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.arr.2024.102211_bib83","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.phrs.2018.03.016","article-title":"Role of ASIC1a in A\u03b2-induced synaptic alterations in the hippocampus","volume":"131","author":"Mango","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.arr.2024.102211_bib84","first-page":"1373","article-title":"LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex","volume":"278","author":"Marek","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.arr.2024.102211_bib85","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3390\/ijms24021329","article-title":"The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology","volume":"24","author":"Mastinu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102211_bib86","first-page":"41","article-title":"Selective serotonin reuptake inhibitors and Alzheimer\u2019s disease","volume":"15","author":"Mdawar","year":"2019","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.arr.2024.102211_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00363","article-title":"Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain","volume":"13","author":"Miranda","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib88","first-page":"1019","article-title":"SIRT1 promotes neuronal fortification in neurodegenerative diseases through attenuation of pathological hallmarks and enhancement of cellular lifespan","volume":"19","author":"Mishra","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2024.102211_bib89","article-title":"Tau and mTOR: the hotspots for multifarious diseases in alzheimer\u2019s development","volume":"12","author":"Mueed","year":"2018","journal-title":"Front Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib90","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1586\/14737175.8.11.1703","article-title":"Cholinergic system during the progression of Alzheimer\u2019s disease: therapeutic implications","volume":"8","author":"Mufson","year":"2008","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.arr.2024.102211_bib91","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer\u2019s disease and the \u03b2-amyloid peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102211_bib92","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrn2303","article-title":"Synaptic plasticity, memory and the hippocampus: a neural network approach to causality","volume":"9","author":"Neves","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib93","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.arr.2024.102211_bib94","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1037\/bul0000108","article-title":"Short-term memory and long-term memory are still different","volume":"143","author":"Norris","year":"2017","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.arr.2024.102211_bib95","doi-asserted-by":"crossref","first-page":"139","DOI":"10.31887\/DCNS.2019.21.2\/dnutt","article-title":"Psychedelic drugs-a new era in psychiatry?","volume":"21","author":"Nutt","year":"2019","journal-title":"Dialog-. Clin. Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib96","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamapsychiatry.2020.2171","article-title":"The Current Status of Psychedelics in Psychiatry","volume":"78","author":"Nutt","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.arr.2024.102211_bib97","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrn3530","article-title":"Effects of Schedule I drug laws on neuroscience research and treatment innovation","volume":"14","author":"Nutt","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41537-017-0037-1","article-title":"The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders","volume":"3","author":"O\u2019Donovan","year":"2017","journal-title":"npj Schizophr."},{"key":"10.1016\/j.arr.2024.102211_bib99","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000356422","article-title":"Memory function and the hippocampus","volume":"34","author":"Opitz","year":"2014","journal-title":"Front Neurol. Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib100","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1755-5949.2008.00059.x","article-title":"The pharmacology of lysergic acid diethylamide: a review","volume":"14","author":"Passie","year":"2008","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.arr.2024.102211_bib101","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.neuro.2010.08.005","article-title":"MDMA administration decreases serotonin but not N-acetylaspartate in the rat brain","volume":"31","author":"Perrine","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.arr.2024.102211_bib102","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/21507740.2022.2148771","article-title":"Journeying to Ixtlan: ethics of psychedelic medicine and research for alzheimer\u2019s disease and related dementias","volume":"14","author":"Peterson","year":"2023","journal-title":"AJOB Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib103","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1007\/s00213-018-5049-7","article-title":"Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting","volume":"235","author":"Prochazkova","year":"2018","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.arr.2024.102211_bib104","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.arr.2024.102211_bib105","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3233\/JAD-160612","article-title":"Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of alzheimer\u2019s disease neurons","volume":"57","author":"Rajmohan","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102211_bib106","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neuropharm.2017.02.003","article-title":"Involvement of GluN2B subunit containing N-methyl-d-aspartate (NMDA) receptors in mediating the acute and chronic synaptotoxic effects of oligomeric amyloid-beta (A\u03b2) in murine models of Alzheimer\u2019s disease (AD)","volume":"123","author":"Rammes","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2024.102211_bib107","doi-asserted-by":"crossref","DOI":"10.1007\/s13205-022-03123-4","article-title":"Hippocampus and its involvement in Alzheimer\u2019s disease: a review","volume":"12","author":"Rao","year":"2022","journal-title":"3 Biotech"},{"key":"10.1016\/j.arr.2024.102211_bib108","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-08047-w","article-title":"Simulated visual hallucinations in virtual reality enhance cognitive flexibility","volume":"12","author":"Rastelli","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102211_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2022.833449","article-title":"AMPA receptor function in hypothalamic synapses","volume":"14","author":"Royo","year":"2022","journal-title":"Front Synaptic Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2017.12.040","article-title":"Psychiatry & the psychedelic drugs. Past, present & future","volume":"142","author":"Rucker","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2024.102211_bib111","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ibra.12094","article-title":"Ketamine as a therapeutic agent in major depressive disorder and posttraumatic stress disorder: Potential medicinal and deleterious effects","volume":"9","author":"Sachdeva","year":"2023","journal-title":"Ibrain"},{"key":"10.1016\/j.arr.2024.102211_bib112","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jnc.15544","article-title":"Psychedelic-inspired approaches for treating neurodegenerative disorders","volume":"162","author":"Saeger","year":"2022","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102211_bib113","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.arr.2024.102211_bib114","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0006-8993(02)03846-5","article-title":"A paired-pulse facilitation analysis of long-term synaptic depression at excitatory synapses in rat hippocampal CA1 and CA3 regions","volume":"962","author":"Santschi","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2024.102211_bib115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2024.102211_bib116","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pbb.2011.12.002","article-title":"Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (\u00b1)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD)","volume":"101","author":"Schindler","year":"2012","journal-title":"Pharmacol. Biochem Behav."},{"key":"10.1016\/j.arr.2024.102211_bib117","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000360925","article-title":"Anatomy of the hippocampal formation","volume":"34","author":"Schultz","year":"2014","journal-title":"Front. Neurol. Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib118","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.3390\/ijms22115991","article-title":"An unbalanced synaptic transmission: cause or consequence of the amyloid oligomers neurotoxicity?","volume":"22","author":"Sciaccaluga","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102211_bib119","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3940(03)00547-0","article-title":"The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats","volume":"346","author":"Scruggs","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2024.102211_bib120","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.mp.4001682","article-title":"Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics","volume":"10","author":"Seeman","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2024.102211_bib121","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1007\/s12035-016-0129-3","article-title":"Neuroprotection through rapamycin-induced activation of autophagy and PI3K\/Akt1\/mTOR\/CREB signaling against amyloid-\u03b2-induced oxidative stress, synaptic\/neurotransmission dysfunction, and neurodegeneration in adult rats","volume":"54","author":"Singh","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2024.102211_bib122","series-title":"Encyclopedia of Animal Cognition and Behavior","author":"Sinha","year":"2022"},{"key":"10.1016\/j.arr.2024.102211_bib123","doi-asserted-by":"crossref","first-page":"a021766","DOI":"10.1101\/cshperspect.a021766","article-title":"Memory consolidation","volume":"7","author":"Squire","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.arr.2024.102211_bib124","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3390\/ph14121213","article-title":"Psilocybin, a naturally occurring indoleamine compound, could be useful to prevent suicidal behaviors","volume":"14","author":"Strumila","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.arr.2024.102211_bib125","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fimmu.2015.00358","article-title":"Psychedelics and immunomodulation: novel approaches and therapeutic opportunities","volume":"6","author":"Szabo","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.arr.2024.102211_bib126","doi-asserted-by":"crossref","first-page":"15556","DOI":"10.1074\/jbc.M112.435123","article-title":"Mammalian Target of Rapamycin (mTor) mediates tau protein dyshomeostasis","volume":"288","author":"Tang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102211_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104793","article-title":"Pharmacological, neural, and psychological mechanisms underlying psychedelics: a critical review","volume":"140","author":"van Elk","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.arr.2024.102211_bib128","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrn2884","article-title":"The neurobiology of psychedelic drugs: implications for the treatment of mood disorders","volume":"11","author":"Vollenweider","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102211_bib129","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cell.2016.12.033","article-title":"Crystal structure of an LSD-bound human serotonin receptor","volume":"168","author":"Wacker","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.arr.2024.102211_bib130","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of glutamate and NMDA receptors in Alzheimer\u2019s disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102211_bib131","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.3390\/ijms23063349","article-title":"Structural plasticity of the hippocampus in neurodegenerative diseases","volume":"23","author":"Weerasinghe-Mudiyanselage","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl 3","key":"10.1016\/j.arr.2024.102211_bib132","first-page":"3","article-title":"Neuropathologic changes in Alzheimer\u2019s disease: potential targets for treatment","volume":"67","author":"Wenk","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.arr.2024.102211_bib133","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(94)92338-8","article-title":"Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer\u2019s disease","volume":"344","author":"West","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2024.102211_bib134","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/bs3020298","article-title":"Hippocampal physiology, structure and function and the neuroscience of schizophrenia: a unified account of declarative memory deficits, working memory deficits and schizophrenic symptoms","volume":"3","author":"Wible","year":"2013","journal-title":"Behav. Sci. (Basel)"},{"key":"10.1016\/j.arr.2024.102211_bib135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.euroneuro.2023.07.003","article-title":"The potential of psychedelics for the treatment of Alzheimer's disease and related dementias","volume":"76","author":"Winkelman","year":"2023","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.arr.2024.102211_bib136","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11011-014-9560-1","article-title":"GABA receptors in brain development, function, and injury","volume":"30","author":"Wu","year":"2015","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.arr.2024.102211_bib137","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/ijnp\/pyab026","article-title":"Psychedelics and consciousness: distinctions, demarcations, and opportunities","volume":"24","author":"Yaden","year":"2021","journal-title":"Int J. Neuropsychopharmacol."},{"key":"10.1016\/j.arr.2024.102211_bib138","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.00082","article-title":"The role of BDNF on neural plasticity in depression","volume":"14","author":"Yang","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"5","key":"10.1016\/j.arr.2024.102211_bib139","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/dneu.20765","article-title":"Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease","volume":"70","author":"Yoshii","year":"2010","journal-title":"Dev Neurobiol."},{"key":"10.1016\/j.arr.2024.102211_bib140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0928-4257(98)80035-1","article-title":"The role of A beta 42 in Alzheimer\u2019s disease","volume":"92","author":"Younkin","year":"1998","journal-title":"J. Physiol. Paris"},{"key":"10.1016\/j.arr.2024.102211_bib141","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-023-00636-1","article-title":"Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer\u2019s disease","volume":"18","author":"Yu","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102211_bib142","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1083\/jcb.200505082","article-title":"Macroautophagy--a novel Beta-amyloid peptide-generating pathway activated in Alzheimer\u2019s disease","volume":"171","author":"Yu","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.arr.2024.102211_bib143","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nature13492","article-title":"Coordinated regulation of protein synthesis and degradation by mTORC1","volume":"513","author":"Zhang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102211_bib144","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/316523","article-title":"Oxidative stress and the pathogenesis of Alzheimer\u2019s disease","volume":"2013","author":"Zhao","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.arr.2024.102211_bib145","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12684","article-title":"Amyloid Beta monomers regulate cyclic adenosine monophosphate response element binding protein functions by activating type-1 insulin-like growth factor receptors in neuronal cells","volume":"17","author":"Zimbone","year":"2018","journal-title":"Aging Cell"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724000291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724000291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T21:51:25Z","timestamp":1718488285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163724000291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":145,"alternative-id":["S1568163724000291"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2024.102211","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2024.102211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102211"}}